The Asia-Pacific antibody discovery market is witnessing robust development, fueled by a rising prevalence of chronic diseases and a enhanced focus on personalized treatment. Significant investment in research and development, particularly within regions like China, Japan, and South Korea, is accelerating the adoption of advanced antibody discov… Read More